Taeang Arai

2.9k total citations
45 papers, 413 citations indexed

About

Taeang Arai is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Taeang Arai has authored 45 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 25 papers in Hepatology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Taeang Arai's work include Liver Disease Diagnosis and Treatment (28 papers), Hepatitis C virus research (14 papers) and Liver Disease and Transplantation (8 papers). Taeang Arai is often cited by papers focused on Liver Disease Diagnosis and Treatment (28 papers), Hepatitis C virus research (14 papers) and Liver Disease and Transplantation (8 papers). Taeang Arai collaborates with scholars based in Japan, United States and South Korea. Taeang Arai's co-authors include Masanori Atsukawa, Katsuhiko Iwakiri, Norio Itokawa, Akihito Tsubota, Chisa Kondo, Tomomi Okubo, Yūji Yoshida, Keizo Kato, Noritomo Shimada and Hiroshi Abe and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Taeang Arai

40 papers receiving 412 citations

Peers

Countries citing papers authored by Taeang Arai

Since Specialization

Citations

This map shows the geographic impact of Taeang Arai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taeang Arai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taeang Arai more than expected).

Fields of papers citing papers by Taeang Arai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taeang Arai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taeang Arai. The network helps show where Taeang Arai may publish in the future.

Co-authorship network of co-authors of Taeang Arai

This figure shows the co-authorship network connecting the top 25 collaborators of Taeang Arai. A scholar is included among the top collaborators of Taeang Arai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taeang Arai. Taeang Arai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Screening Data for Liver Fibrosis in Psoriasis Patients Treated with Biologics 2024 ·Journal of Nippon Medical School ·Susumu Ichiyama, Michiko Ito, (unknown), Taeang Arai, Masanori Atsukawa, Katsuhiko Iwakiri, Teppei Hagino, Toshihiko Hoashi, Naoko Kanda, Hidehisa Saeki	0
2	Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction‐associated steatotic liver disease: A prospective, multicentre, observational study 2024 ·Diabetes Obesity and Metabolism ·Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Tsunekazu Oikawa, Toshifumi Tada, (unknown), Toru Ishikawa, Hiroshi Abe, Keizo Kato, Asahiro Morishita, Joji Tani, Tomomi Okubo, Mototsugu Nagao, (unknown), Katsuhiko Iwakiri	15
3	Limited use of FIB‐4 index in patients under 65 years of age with type 2 diabetes mellitus 2024 ·Hepatology Research ·Mimi Kim, Eileen L. Yoon, Huiyul Park, Takanori Ito, Masatoshi Ishigami, (unknown), Chul‐min Lee, Bo‐Kyeong Kang, Hye‐Lin Kim, Taeang Arai, Masanori Atsukawa, Miwa Kawanaka, Hidenori Toyoda, Ming‐Lung Yu, Dae Won Jun, Mindie H. Nguyen	1
4	Low vitamin D levels accelerates muscle mass loss in patients with chronic liver disease 2024 ·PLoS ONE ·Tomomi Okubo, Masanori Atsukawa, Akihito Tsubota, Hiroki Ono, (unknown), Yūji Yoshida, Taeang Arai, (unknown), Norio Itokawa, Chisa Kondo, Katsuhiko Iwakiri	1
5	Impact of oral semaglutide on liver pathology and glucose metabolism in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus 2023 ·Journal of Hepatology ·(unknown), Masanori Atsukawa, Tomomi Okubo, Taeang Arai, Norio Itokawa, Akihito Tsubota, Tsunekazu Oikawa, Toru Ishikawa, Toshifumi Tada, Hiroshi Abe, Keizo Kato, Joji Tani, Asahiro Morishita, (unknown), Katsuhiko Iwakiri	0
6	How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by portal hypertension? A post hoc analysis 2023 ·JGH Open ·Masanori Atsukawa, Akihito Tsubota, Yuichi Tamura, (unknown), (unknown), Tomomi Okubo, Korenobu Hayama, Taeang Arai, Norio Itokawa, Yu Taniguchi, (unknown), Chisa Kondo, Katsuhiko Iwakiri	2
7	Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease 2023 ·JAMA Network Open ·Huiyul Park, Eileen L. Yoon, Takanori Ito, (unknown), Mimi Kim, Jonghyun Lee, Hye‐Lin Kim, Taeang Arai, Masanori Atsukawa, Miwa Kawanaka, Hidenori Toyoda, Masatoshi Ishigami, Ming‐Lung Yu, Dae Won Jun, Mindie H. Nguyen	17
8	Misunderstanding of hepatitis C virus (HCV) infection status by non–specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy 2022 ·Journal of Infection and Chemotherapy ·Hidenori Toyoda, Satoshi Yasuda, Akio Moriya, Ei Itobayashi, Haruki Uojima, Tsunamasa Watanabe, Masanori Atsukawa, Taeang Arai, Toru Ishikawa, Shigeru Mikami, Atsushi Hiraoka, Kunihiko Tsuji, Tsunekazu Oikawa, Akihito Tsubota, Akito Nozaki, Makoto Chuma, Hiroshi Abe, Toshihide Shima, Takashi Kumada, Junko Tanaka	1
9	Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease 2022 ·Scientific Reports ·(unknown), Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hidenori Toyoda, Koichi Takaguchi, Joji Tani, Asahiro Morishita, Atsushi Hiraoka, Shigeru Mikami, Toru Ishikawa, Hironao Okubo, Tsunamasa Watanabe, Tomomi Okubo, Taeang Arai, Korenobu Hayama, Norio Itokawa, Chisa Kondo, Katsuhiko Iwakiri	2
10	Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients 2022 ·Clinical Gastroenterology and Hepatology ·Takanori Ito, Vy H. Nguyen, Taku Tanaka, Huiyul Park, Ming‐Lun Yeh, Miwa Kawanaka, Taeang Arai, Masanori Atsukawa, Eileen L. Yoon, Pei‐Chien Tsai, Hidenori Toyoda, Jee‐Fu Huang, Linda Henry, Dae Won Jun, Ming‐Lung Yu, Masatoshi Ishigami, Mindie H. Nguyen, Ramsey Cheung	20
11	Type III Procollagen Peptide Level can Indicate Liver Dysfunction Associated with Volume Overload in Acute Heart Failure 2022 ·ESC Heart Failure ·Akihiro Shirakabe, Hirotake Okazaki, M. Matsushita, Yusaku Shibata, (unknown), Suguru Nishigoori, (unknown), (unknown), (unknown), Masanori Atsukawa, Norio Itokawa, Taeang Arai, Nobuaki Kobayashi, Kuniya Asai	7
12	The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency 2021 ·Digestive Diseases ·Xue Shao, Haruki Uojima, Taeang Arai, Yuji Ogawa, Toru Setsu, Masanori Atsukawa, Yoshihiro Furuichi, Yoshitaka Arase, (unknown), Hisashi Hidaka, Takahide Nakazawa, Makoto Kako, Tatehiro Kagawa, Katsuhiko Iwakiri, Atsushi Nakajima, Shuji Terai, Yasuhito Tanaka, Wasaburo Koizumi	8
13	Development of interferon-free, direct-acting antivirals treatment for Japanese patients with chronic hepatitis C infection and chronic kidney disease 2021 ·Journal of Nippon Medical School ·Masanori Atsukawa, Chisa Kondo, (unknown), Tomomi Okubo, Taeang Arai, (unknown), Norio Itokawa, Katsuhiko Iwakiri	2
14	Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B 2021 ·Internal Medicine ·Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hidenori Toyoda, Koichi Takaguchi, Atsushi Hiraoka, Tomonori Senoh, (unknown), Yūji Yoshida, Tomomi Okubo, Taeang Arai, Korenobu Hayama, (unknown), Chisa Kondo, Katsuhiko Iwakiri	3
15	Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression 2018 ·PLoS ONE ·(unknown), Masanori Atsukawa, Katsuhisa Nakatsuka, Masumi Shimizu, Daishu Miura, Taeang Arai, Hirotomo Harimoto, Chisa Kondo, Keiko Kaneko, Seiji Futagami, Chiaki Kawamoto, Hidemi Takahashi, Katsuhiko Iwakiri	9
16	Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment 2018 ·Hepatology International ·Tomomi Okubo, Masanori Atsukawa, Akihito Tsubota, Hidenori Toyoda, Noritomo Shimada, Hiroshi Abe, Keizo Kato, Korenobu Hayama, Taeang Arai, (unknown), Norio Itokawa, Chisa Kondo, Chiaki Kawamoto, Etsuko Iio, Yasuhito Tanaka, Takashi Kumada, Katsuhiko Iwakiri	16
17	A Case of Sjögren's Syndrome Complicated with Interstitial Nephritis and Delayed Onset Autoimmune Hepatitis 2018 ·Journal of Nippon Medical School ·Takehisa Yamada, (unknown), Tetsuya Kashiwagi, Taeang Arai, Norio Itokawa, Masanori Atsukawa, Akira Shimizu, Shuichi Tsuruoka	1
18	Serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein more reliably distinguishes liver fibrosis stages in non‐alcoholic fatty liver disease than serum Mac‐2 binding protein 2017 ·Hepatology Research ·Masanori Atsukawa, Akihito Tsubota, Tomomi Okubo, Taeang Arai, (unknown), Norio Itokawa, Chisa Kondo, Keizo Kato, Tsutomu Hatori, Hiroshi Hano, Tsunekazu Oikawa, Naoya Emoto, Masanori Abe, Masayoshi Kage, Katsuhiko Iwakiri	14
19	Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C 2017 ·Digestive and Liver Disease ·Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Noritomo Shimada, Hiroshi Abe, Keizo Kato, Tomomi Okubo, Taeang Arai, Norio Itokawa, Etsuko Iio, Yasuhito Tanaka, Katsuhiko Iwakiri	11
20	Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients 2016 ·World Journal of Gastroenterology ·(unknown), Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Tomomi Okubo, Taeang Arai, Norio Itokawa, Yoshiyuki Narahara, Katsuhiko Iwakiri	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact